<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A number of publications have provided valuable insight into and data on the epidemiology, pathogenesis, diagnosis, risk factor evaluation, and treatment of patients with <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Although the incidence of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> has rapidly increased over the past two decades, it is not clear whether there has been a parallel increase in the frequency of <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The issue of surveillance endoscopy in patients with <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> remains controversial; prospective data are still lacking </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0005403" disease_type="Disease or Syndrome" abbrv="">Bile reflux</z:e> plays an important role in the pathogenesis of <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo>; however, this usually occurs in the presence of acid </plain></SENT>
<SENT sid="4" pm="."><plain>Newer technology and techniques, including chromoendoscopy, magnification endoscopy, optical coherence tomography, and spectroscopy, have opened the field by providing a more accurate and "nonbiopsy" diagnosis of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> and <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>The field of biomarkers remains continues to expand and is providing insight into risk stratification of patients with <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The exact role of acid suppression in patients with this premalignant disease remains controversial, and endoscopic therapies appear promising </plain></SENT>
</text></document>